Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Coverage of Measles-Containing Vaccine in the Study Population
3.2. Determinants of Measles Vaccination Coverage
3.3. Individuals Refusing Measles Vaccination
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Global Measles and Rubella Strategic Plan 2012-2020, World Health Organization: Switzerland, 2012. Available online: https://www.who.int/publications/i/item/9789241503396 (accessed on 6 February 2023).
- UK Health Security Agency. Guidance: UK Measles and Rubella Elimination Indicators and Status. UK Health Security Agency, 2022. Available online: https://www.gov.uk/government/publications/measles-and-rubella-elimination-uk/uk-measles-and-rubella-elimination (accessed on 6 February 2023).
- Currie, J.; Davies, L.; McCarthy, J.; Perry, M.; Moore, C.; Cottrell, S.; Bowley, M.; Williams, C.; Shankar, A.G.; Stiff, R. Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017. Euro Surveill. 2017, 22, 17–00673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- le Polain de Waroux, O.; Saliba, V.; Cottrell, S.; Young, N.; Perry, M.; Bukasa, A.; Ramsay, M.; Brown, K.; Amirthalingam, G. Summer music and arts festivals as hot spots for measles transmission: Experience from England and Wales, June to October 2016. Euro Surveill. 2016, 21, 30390. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- UK Health Security Agency. Confirmed Cases of Measles in England and Wales by Region and Age: 2012 to 2021. UK Health Security Agency, 2022. Available online: https://www.gov.uk/government/publications/measles-confirmed-cases/confirmed-cases-of-measles-in-england-and-wales-by-region-and-age-2012-to-2014 (accessed on 6 February 2023).
- Public Health Wales. Wales Measles and Rubella Elimination Task Group Action Plan 2019–2021, Public Health Wales: Cardiff, 2019. Available online: https://phw.nhs.wales/topics/measles/wales-measles-and-rubella-elimination-task-group-action-plan-2019-2021/ (accessed on 6 February 2023).
- COVER–National Childhood Immunisation Uptake Data. Public Health Wales, 2022. Available online: https://phw.nhs.wales/topics/immunisation-and-vaccines/cover-national-childhood-immunisation-uptake-data/ (accessed on 6 February 2023).
- Public Health Wales. Inequalities in Uptake of Routine Childhood Immunisations in Wales 2021–2022; Public Health Wales: Cardiff, Wales, 2022; Available online: https://phw.nhs.wales/topics/immunisation-and-vaccines/cover-national-childhood-immunisation-uptake-data/cover-inequalities-reports/inequalities-in-uptake-of-routine-childhood-immunisations-in-wales-2021-22/ (accessed on 6 February 2023).
- World Health Organization Regional Office for Europe. European Immunization Agenda 2030, World Health Organization: Copenhagen, 2021. Available online: https://www.who.int/europe/initiatives/the-european-immunization-agenda-2030 (accessed on 6 February 2023).
- Bocquier, A.; Ward, J.; Raude, J.; Peretti-Watel, P.; Verger, P. Socioeconomic differences in childhood vaccination in developed countries: A systematic review of quantitative studies. Expert Rev. Vaccines 2017, 16, 1107–1118. [Google Scholar] [CrossRef] [PubMed]
- Gilbert, N.L.; Gilmour, H.; Wilson, S.E.; Cantin, L. Determinants of non-vaccination and incomplete vaccination in Canadian toddlers. Hum. Vaccin. Immunother. 2017, 13, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pearce, A.; Law, C.; Elliman, D.; Cole, T.J.; Bedford, H.; Millennium Cohort Study Child Health Group. Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: Prospective cohort study. BMJ. 2008, 336, 754–757. [Google Scholar] [CrossRef] [Green Version]
- Foty, R.G.; Guttmann, A.; Kwong, J.C.; Maaten, S.; Manuel, D.; Stieb, D.M.; Dell, S.D. Predictors of universal influenza vaccination uptake in grades 1 and 2 Toronto school children: Effective vaccination strategies should not end with at risk children. Vaccine 2010, 28, 6518–6522. [Google Scholar] [CrossRef]
- Ahmed Ali, H.; Hartner, A.M.; Echeverria-Londono, S.; Roth, J.; Li, X.; Abbas, K.; Portnoy, A.; Vynnycky, E.; Woodruff, K.; Ferguson, N.M.; et al. Vaccine equity in low and middle income countries: A systematic review and meta-analysis. Int. J. Equity Health 2022, 21, 82. [Google Scholar] [CrossRef]
- Pearce, A.; Marshall, H.; Bedford, H.; Lynch, J. Barriers to childhood immunisation: Findings from the Longitudinal Study of Australian Children. Vaccine 2015, 33, 3377–3383. [Google Scholar] [CrossRef] [Green Version]
- Stronegger, W.J.; Freid, W. A hierarchical analysis of social determinants of measles vaccination coverage in Austrian schoolchildren. Eur. J. Public Health 2010, 20, 354–359. [Google Scholar] [CrossRef]
- Tiley, K.S.; White, J.M.; Andrews, N.; Tessier, E.; Edelstein, M. Equity of the Meningitis B vaccination programme in England, 2016-2018. Vaccine 2022, 40, 6125–6132. [Google Scholar] [CrossRef]
- Arat, A.; Moore, H.C.; Goldfeld, S.; Östberg, V.; Sheppeard, V.; Gidding, H.F. Childhood vaccination coverage in Australia: An equity perspective. BMC Public Health 2021, 21, 1337. [Google Scholar] [CrossRef]
- Doherty, E.; Walsh, B.; O’Neill, C. Decomposing socioeconomic inequality in child vaccination: Results from Ireland. Vaccine 2014, 32, 3438–3444. [Google Scholar] [CrossRef] [PubMed]
- Tessier, E.; Warburton, F.; Tsang, C.; Rafeeq, S.; Boddington, N.; Sinnathamby, M.; Pebody, R. Population-level factors predicting variation in influenza vaccine uptake among adults and young children in England, 2015/16 and 2016/17. Vaccine 2018, 36, 3231–3238. [Google Scholar] [CrossRef] [PubMed]
- Jones, K.H.; Ford, D.V.; Thompson, S.; Lyons, R.A. A Profile of the SAIL Databank on the UK Secure Research Platform. Int. J. Popul. Data Sci. 2019, 4, 1134. [Google Scholar] [CrossRef] [Green Version]
- Thayer, D.; Rees, A.; Kennedy, J.; Collins, H.; Harris, D.; Halcox, J.; Ruschetti, L.; Noyce, R.; Brooks, C. Measuring follow-up time in routinely-collected health datasets: Challenges and solutions. PLoS ONE 2020, 15, e0228545. [Google Scholar] [CrossRef] [PubMed]
- UK Health Security Agency. Measles: The Green Book, Chapter 21; UK Health Security Agency: London, UK, 2019. Available online: https://www.gov.uk/government/publications/measles-the-green-book-chapter-21 (accessed on 6 February 2023).
- Perry, M.; Akbari, A.; Cottrell, S.; Gravenor, M.B.; Roberts, R.; Lyons, R.A.; Bedston, S.; Torabi, F.; Griffiths, L. Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK. Vaccine 2021, 39, 6256–6261. [Google Scholar] [CrossRef]
- CPRD @ Cambridge–Codes Lists (GOLD). University of Cambridge, 2018. Available online: https://www.phpc.cam.ac.uk/pcu/research/research-groups/crmh/cprd_cam/codelists/v11/ (accessed on 6 February 2023).
- Open Code Lists, Wider Learning Disability. Available online: https://www.opencodelists.org/codelist/primis-covid19-vacc-uptake/learndis/v.1.5.3/ (accessed on 6 February 2023).
- Metcalfe, D.; Masters, J.; Delmestri, A.; Judge, A.; Perry, D.; Zogg, C.; Gabbe, B.; Costa, M. Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases. BMC Med. Res. Methodol. 2019, 19, 115. [Google Scholar] [CrossRef] [PubMed]
- Wilder-Smith, A.B.; Qureshi, K. Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine. J. Epidemiol Glob. Health 2020, 10, 46–58. [Google Scholar] [CrossRef] [Green Version]
- Nimblett-Clarke, A. The role of vaccine exemptions in the resurgence of measles. JAAPA. 2021, 34, 36–40. [Google Scholar] [CrossRef]
- Pearce, A.; Mindlin, M.; Cortina-Borja, M.; Bedford, H. Characteristics of 5-year-olds who catch-up with MMR: Findings from the UK Millennium Cohort Study. BMJ Open 2013, 3, e003152. [Google Scholar] [CrossRef] [Green Version]
- Wightman, P.; McCue, K.; Sabo, S.; Annorbah, R.; Jiménez, D.; Pilling, V.; Butler, M.; Celaya, M.F.; Rumann, S. Community health worker intervention improves early childhood vaccination rates: Results from a propensity-score matching evaluation. BMC Public Health 2022, 22, 1854. [Google Scholar] [CrossRef] [PubMed]
- Sangster, A.V.; Barratt, J.M. Towards Ending Immunization Inequity. Vaccines 2021, 9, 1378. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization Regional Office for Europe. TIP–Tailoring Immunization Programmes; World Health Organization: Copenhagen, Denmark, 2019; Available online: https://apps.who.int/iris/bitstream/handle/10665/329448/9789289054492-eng.pdf?sequence=1&isAllowed=y (accessed on 6 February 2023).
- Jama, A.; Appelqvist, E.; Kulane, A.; Karregård, S.; Rubin, J.; Nejat, S.; Habersaat, K.B.; Jackson, C.; Butler, R.; Lindstrand, A.; et al. Design and implementation of tailored intervention to increase vaccine acceptance in a Somali community in Stockholm, Sweden–based on the Tailoring Immunization Programmes approach. Public Health Pract 2022, 4, 100305. [Google Scholar] [CrossRef] [PubMed]
- Rojas-Venegas, M.; Cano-Ibáñez, N.; Khan, K.S. Vaccination coverage among migrants: A systematic review and meta-analysis. Semergen 2022, 48, 96–105. [Google Scholar] [CrossRef] [PubMed]
- Mipatrini, D.; Stefanelli, P.; Severoni, S.; Rezza, G. Vaccinations in migrants and refugees: A challenge for European health systems. A systematic review of current scientific evidence. Pathog. Glob. Health. 2017, 111, 59–68. [Google Scholar] [CrossRef] [Green Version]
- UK Health Security Agency. Vaccination of Individuals with Uncertain Or Incomplete Immunisation Status; UK Health Security Agency: London, UK, 2022. Available online: https://www.gov.uk/government/publications/vaccination-of-individuals-with-uncertain-or-incomplete-immunisation-status (accessed on 6 February 2023).
- Bell, S.; Saliba, V.; Ramsay, M.; Mounier-Jack, S. What have we learnt from measles outbreaks in 3 English cities? A qualitative exploration of factors influencing vaccination uptake in Romanian and Roma Romanian communities. BMC Public Health 2020, 20, 381. [Google Scholar] [CrossRef]
- Jackson, C.; Bedford, H.; Cheater, F.M.; Condon, L.; Emslie, C.; Ireland, L.; Kemsley, P.; Kerr, S.; Lewis, H.J.; Mytton, H.; et al. Needles, Jabs and Jags: A qualitative exploration of barriers and facilitators to child and adult immunisation uptake among Gypsies, Travellers and Roma. BMC Public Health 2017, 17, 254. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. COVID-19 Pandemic Leads to Major Backsliding On Childhood Vaccinations, New WHO, UNICEF Data Shows; World Health Organization: Geneva, Switzerland, 2021; Available online: https://www.who.int/news/item/15-07-2021-covid-19-pandemic-leads-to-major-backsliding-on-childhood-vaccinations-new-who-unicef-data-shows (accessed on 6 February 2023).
- European Centre for Disease Control. Monthly Measles And Rubella Monitoring; ECDC: Stockholm, Sweden, 2022; Available online: https://www.ecdc.europa.eu/en/measles/surveillance-and-disease-data/monthly-measles-rubella-monitoring-reports (accessed on 6 February 2023).
Characteristic | Category | One Dose of Measles-Containing Vaccine (4–25 Year Olds) | Two Doses of Measles-Containing Vaccine (4–25 Year Olds) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Vaccinated (n) | Population (n) | Uptake (%) | OR (95% CI) | aOR (95% CI) | Vaccinated (n) | Population (n) | Uptake (%) | OR (95% CI) | aOR (95% CI) | ||
Gender | Male | 213,518 | 215,626 | 99.0 | Baseline | Baseline | 208,567 | 215,626 | 96.7 | Baseline | Baseline |
Female | 202,068 | 203,779 | 99.2 | 1.17 (1.09–1.24) | 1.11 (1.03–1.18) | 197,973 | 203,779 | 97.2 | 1.15 (1.11–1.20) | 1.11 (1.07–1.15) | |
Age cohort | Primary school (4–11) | 132,916 | 133,857 | 99.3 | Baseline | Baseline | 130,258 | 133,857 | 97.3 | Baseline | Baseline |
Secondary school (12–16) | 109,335 | 110,028 | 99.4 | 1.12 (1.01–1.23) | 1.38 (1.24–1.52) | 107,809 | 110,028 | 98.0 | 1.34 (1.27–1.42) | 1.60 (1.51–1.69) | |
College (17–18) | 40,779 | 41,175 | 99.0 | 0.73 (0.65–0.82) | 0.90 (0.80–1.02) | 39,946 | 41,175 | 97.0 | 0.90 (0.84–0.96) | 1.08 (1.01–1.16) | |
University (19–21) | 54,384 | 55,079 | 98.7 | 0.55 (0.50–0.61) | 0.70 (0.63–0.78) | 52,902 | 55,079 | 96.0 | 0.67 (0.64–0.71) | 0.83 (0.78–0.88) | |
Young adults (22–25) | 78,172 | 79,266 | 98.6 | 0.51 (0.46–0.55) | 0.66 (0.60–0.73) | 75,625 | 79,266 | 95.4 | 0.57 (0.55–0.60) | 0.73 (0.69–0.77) | |
Health board of residence | HB1 | 81,805 | 82,299 | 99.4 | Baseline | Baseline | 80,763 | 82,299 | 98.1 | Baseline | Baseline |
HB2 | 57,912 | 58,599 | 98.8 | 0.51 (0.45–0.57) | 0.51 (0.45–0.57) | 56,282 | 58,599 | 96.0 | 0.46 (0.43–0.49) | 0.46 (0.43–0.49) | |
HB3 | 43,403 | 44,002 | 98.6 | 0.44 (0.39–0.49) | 0.44 (0.39–0.49) | 42,355 | 44,002 | 96.3 | 0.49 (0.46–0.52) | 0.47 (0.44–0.50) | |
HB4 | 6801 | 6902 | 98.5 | 0.41 (0.33–0.51) | 0.38 (0.31–0.48) | 6636 | 6902 | 96.1 | 0.47 (0.42–0.54) | 0.45 (0.39–0.51) | |
HB5 | 76,485 | 77,197 | 99.1 | 0.65 (0.58–0.73) | 0.62 (0.55–0.69) | 74,573 | 77,197 | 96.6 | 0.54 (0.51–0.58) | 0.54 (0.51–0.58) | |
HB6 | 79,422 | 80,048 | 99.2 | 0.77 (0.68–0.86) | 0.76 (0.68–0.86) | 77,768 | 80,048 | 97.2 | 0.65 (0.61–0.69) | 0.66 (0.62–0.71) | |
HB7 | 69,758 | 70,358 | 99.1 | 0.70 (0.62–0.79) | 0.80 (0.71–0.91) | 68,163 | 70,358 | 96.9 | 0.59 (0.55–0.63) | 0.64 (0.60–0.68) | |
Deprivation quintile of residence | Most deprived | 97,159 | 98,266 | 98.9 | Baseline | Baseline | 94,183 | 98,266 | 95.8 | Baseline | Baseline |
2 | 87,377 | 88,209 | 99.1 | 1.20 (1.09–1.31) | 1.06 (0.97–1.17) | 85,432 | 88,209 | 96.9 | 1.33 (1.27–1.40) | 1.15 (1.09–1.21) | |
3 | 75,674 | 76,343 | 99.1 | 1.29 (1.17–1.42) | 1.10 (1.00–1.23) | 74,185 | 76,343 | 97.2 | 1.49 (1.41–1.57) | 1.16 (1.10–1.23) | |
4 | 72,632 | 73,239 | 99.2 | 1.36 (1.23–1.51) | 1.11 (0.99–1.23) | 71,339 | 73,239 | 97.4 | 1.63 (1.54–1.72) | 1.18 (1.11–1.26) | |
Least deprived | 82,744 | 83,348 | 99.3 | 1.56 (1.41–1.73) | 1.13 (1.01–1.26) | 81,401 | 83,348 | 97.7 | 1.81 (1.72–1.91) | 1.22 (1.15–1.30) | |
Ethnic group | White | 392,908 | 396,329 | 99.1 | Baseline | Baseline | 384,621 | 396,329 | 97.0 | Baseline | Baseline |
Other | 1817 | 1868 | 97.3 | 0.31 (0.24–0.42) | 1.08 (0.77–1.54) | 1745 | 1868 | 93.4 | 0.43 (0.36–0.52) | 1.08 (0.86–1.36) | |
Asian | 9762 | 9900 | 98.6 | 0.62 (0.52–0.73) | 1.58 (1.27–1.97) | 9473 | 9900 | 95.7 | 0.68 (0.61–0.75) | 1.31 (1.14–1.50) | |
Mixed | 9201 | 9338 | 98.5 | 0.58 (0.49–0.70) | 0.76 (0.64–0.92) | 8920 | 9338 | 95.5 | 0.65 (0.59–0.72) | 0.78 (0.71–0.87) | |
Black | 1898 | 1970 | 96.3 | 0.23 (0.18–0.29) | 0.99 (0.75–1.33) | 1781 | 1970 | 90.4 | 0.29 (0.25–0.33) | 0.92 (0.77–1.11) | |
Comorbidity score | 0 | 328,434 | 331,538 | 99.1 | Baseline | Baseline | 32,1268 | 331,538 | 96.9 | Baseline | Baseline |
1 | 79,664 | 80,288 | 99.2 | 1.21 (1.11–1.32) | 1.17 (1.07–1.28) | 77,985 | 80,288 | 97.1 | 1.08 (1.03–1.13) | 1.10 (1.05–1.16) | |
2 | 5353 | 5404 | 99.1 | 0.99 (0.76–1.33) | 1.03 (0.78–1.39) | 5209 | 5404 | 96.4 | 0.85 (0.74–0.99) | 0.95 (0.82–1.10) | |
3+ | 2135 | 2175 | 98.2 | 0.50 (0.37–0.70) | 0.58 (0.42–0.81) | 2078 | 2175 | 95.5 | 0.68 (0.56–0.85) | 0.87 (0.71–1.09) | |
Age first registered with primary care GP in Wales | At birth | 358,121 | 360,620 | 99.3 | Baseline | Baseline | 351,458 | 360,620 | 97.5 | Baseline | Baseline |
Young child (2–3) | 33,881 | 34,335 | 98.7 | 0.52 (0.47–0.58) | 0.70 (0.63–0.78) | 32,798 | 34,335 | 95.5 | 0.56 (0.53–0.59) | 0.69 (0.65–0.73) | |
Primary school (4–11) | 11,535 | 12,120 | 95.2 | 0.14 (0.13–0.15) | 0.31 (0.27–0.35) | 10,663 | 12,120 | 88.0 | 0.19 (0.18–0.20) | 0.36 (0.33–0.39) | |
Secondary school (12–16) | 1609 | 1761 | 91.4 | 0.07 (0.06–0.09) | 0.16 (0.13–0.20) | 1472 | 1761 | 83.6 | 0.13 (0.12–0.15) | 0.25 (0.22–0.29) | |
College (17–18) | 672 | 691 | 97.3 | 0.25 (0.16–0.40) | 0.37 (0.24–0.61) | 645 | 691 | 93.3 | 0.37 (0.27–0.50) | 0.53 (0.39–0.73) | |
University (19–21) | 5266 | 5330 | 98.8 | 0.57 (0.45–0.74) | 0.70 (0.54–0.91) | 5133 | 5330 | 96.3 | 0.68 (0.59–0.79) | 0.78 (0.68–0.91) | |
Young adult (22–25) | 4502 | 4548 | 99.0 | 0.68 (0.52–0.93) | 0.84 (0.63–1.15) | 4371 | 4548 | 96.1 | 0.64 (0.55–0.75) | 0.77 (0.66–0.90) | |
Mother’s age at delivery | Under 17 | 2987 | 3002 | 99.5 | 1.69 (1.05–2.95) | 1.91 (1.18–3.37) | 2905 | 3002 | 96.8 | 0.90 (0.74–1.11) | 0.97 (0.79–1.20) |
17–18 | 14,508 | 14,610 | 99.3 | 1.21 (0.99–1.49) | 1.30 (1.05–1.62) | 14,143 | 14,610 | 96.8 | 0.91 (0.83–1.01) | 0.92 (0.83–1.02) | |
19–20 | 26,875 | 27,051 | 99.3 | 1.30 (1.11–1.53) | 1.33 (1.13–1.58) | 26,293 | 27,051 | 97.2 | 1.04 (0.97–1.13) | 1.03 (0.95–1.13) | |
21–25 | 95,435 | 96,284 | 99.1 | 0.95 (0.87–1.05) | 1.02 (0.93–1.12) | 93,125 | 96,284 | 96.7 | 0.89 (0.85–0.93) | 0.92 (0.88–0.97) | |
26–30 | 125,482 | 126,548 | 99.2 | Baseline | Baseline | 122,849 | 126,548 | 97.1 | Baseline | Baseline | |
31–35 | 102,444 | 103,414 | 99.1 | 0.90 (0.82–0.98) | 0.88 (0.80–0.96) | 100,419 | 103,414 | 97.1 | 1.01 (0.96–1.06) | 0.99 (0.94–1.04) | |
36–40 | 41,039 | 41,555 | 98.8 | 0.68 (0.61–0.75) | 0.70 (0.63–0.78) | 40,176 | 41,555 | 96.7 | 0.88 (0.82–0.93) | 0.91 (0.85–0.97) | |
Over 40 | 6816 | 6941 | 98.2 | 0.46 (0.39–0.56) | 0.60 (0.49–0.73) | 6630 | 6941 | 95.5 | 0.64 (0.57–0.72) | 0.79 (0.70–0.90) | |
Birth order | First born | 160,101 | 160,931 | 99.5 | Baseline | Baseline | 157,847 | 160,931 | 98.1 | Baseline | Baseline |
Second born | 182,014 | 183,880 | 99.0 | 0.51 (0.47–0.55) | 0.74 (0.68–0.81) | 177,856 | 183,880 | 96.7 | 0.58 (0.55–0.60) | 0.70 (0.66–0.73) | |
Third born | 48,304 | 48,845 | 98.9 | 0.46 (0.42–0.52) | 0.54 (0.49–0.61) | 46,895 | 48,845 | 96.0 | 0.47 (0.44–0.50) | 0.50 (0.47–0.53) | |
Forth born | 16,425 | 16,726 | 98.2 | 0.28 (0.25–0.32) | 0.37 (0.32–0.43) | 15,713 | 16,726 | 93.9 | 0.30 (0.28–0.33) | 0.35 (0.33–0.38) | |
Fifth born | 5506 | 5658 | 97.3 | 0.19 (0.16–0.22) | 0.27 (0.23–0.33) | 5209 | 5658 | 92.1 | 0.23 (0.20–0.25) | 0.29 (0.26–0.32) | |
Sixth or more | 3236 | 3365 | 96.2 | 0.13 (0.11–0.16) | 0.21 (0.17–0.26) | 3020 | 3365 | 89.7 | 0.17 (0.15–0.19) | 0.23 (0.20–0.26) | |
Total primary care GP visits 1 September 2020 to 31 August 2021 | None | 38,114 | 38,843 | 98.1 | Baseline | Baseline | 36,931 | 38,843 | 95.1 | Baseline | Baseline |
1–2 | 114,209 | 115,168 | 99.2 | 2.28 (2.07–2.51) | 2.18 (1.97–2.41) | 111,863 | 115,168 | 97.1 | 1.75 (1.65–1.86) | 1.72 (1.62–1.83) | |
3–4 | 72,737 | 73,290 | 99.2 | 2.52 (2.25–2.81) | 2.53 (2.25–2.84) | 71,298 | 73,290 | 97.3 | 1.85 (1.74–1.98) | 1.92 (1.80–2.05) | |
5–9 | 90,044 | 90,745 | 99.2 | 2.46 (2.21–2.73) | 2.52 (2.26–2.81) | 88,290 | 90,745 | 97.3 | 1.86 (1.75–1.98) | 1.98 (1.86–2.11) | |
10–14 | 40,422 | 40,743 | 99.2 | 2.41 (2.11–2.75) | 2.64 (2.30–3.04) | 39,565 | 40,743 | 97.1 | 1.74 (1.62–1.87) | 1.97 (1.82–2.13) | |
15–19 | 23,819 | 23,992 | 99.3 | 2.63 (2.24–3.12) | 3.06 (2.57–3.65) | 23,298 | 23,992 | 97.1 | 1.74 (1.59–1.90) | 2.09 (1.91–2.30) | |
20–24 | 13,989 | 14,122 | 99.1 | 2.01 (1.68–2.43) | 2.43 (2.01–2.97) | 13,632 | 14,122 | 96.5 | 1.44 (1.30–1.60) | 1.82 (1.64–2.03) | |
25–49 | 19,737 | 19,952 | 98.9 | 1.76 (1.51–2.05) | 2.31 (1.96–2.74) | 19,222 | 19,952 | 96.3 | 1.36 (1.25–1.49) | 1.88 (1.71–2.07) | |
50+ | 2515 | 2550 | 98.6 | 1.37 (0.99–1.97) | 2.12 (1.51–3.09) | 2441 | 2550 | 95.7 | 1.16 (0.96–1.42) | 1.90 (1.55–2.35) | |
Recorded language | No | 5525 | 5863 | 94.2 | Baseline | Baseline | 5170 | 5863 | 88.2 | Baseline | Baseline |
English or Welsh | Yes | 410,061 | 413,542 | 99.2 | 7.21 (6.41–8.07) | 1.71 (1.44–2.03) | 401,370 | 413,542 | 97.1 | 4.42 (4.07–4.79) | 1.33 (1.18–1.49) |
Ever eligible for | No | 296,942 | 299,262 | 99.2 | Baseline | Baseline | 291,750 | 299,262 | 97.5 | Baseline | Baseline |
free school meals | Yes | 118,644 | 120,143 | 98.8 | 0.62 (0.58–0.66) | 0.73 (0.68–0.79) | 114,790 | 120,143 | 95.5 | 0.55 (0.53–0.57) | 0.73 (0.70–0.76) |
Ever attended a | No | 410,837 | 414,573 | 99.1 | Baseline | Baseline | 402,105 | 414,573 | 97.0 | Baseline | Baseline |
special school | Yes | 4749 | 4832 | 98.3 | 0.52 (0.42–0.65) | 0.67 (0.53–0.85) | 4435 | 4832 | 91.8 | 0.35 (0.31–0.38) | 0.43 (0.39–0.48) |
None | 59,223 | 60,034 | 98.6 | Baseline | Baseline | 57,107 | 60,034 | 95.1 | Baseline | Baseline | |
Mother’s highest qualification | A–levels | 63,435 | 63,907 | 99.3 | 1.84 (1.64–2.06) | 1.12 (0.99–1.27) | 62,375 | 63,907 | 97.6 | 2.09 (1.96–2.22) | 1.25 (1.17–1.34) |
GCSE/O–Level high grades | 85,168 | 85,779 | 99.3 | 1.91 (1.72–2.12) | 1.25 (1.12–1.40) | 83,527 | 85,779 | 97.4 | 1.90 (1.80–2.01) | 1.25 (1.17–1.32) | |
GCSE/O–Level any grades | 74,792 | 75,459 | 99.1 | 1.54 (1.39–1.70) | 1.10 (0.99–1.22) | 72,997 | 75,459 | 96.7 | 1.52 (1.44–1.61) | 1.11 (1.04–1.17) | |
Degree | 120,598 | 121,585 | 99.2 | 1.67 (1.52–1.84) | 1.10 (0.98–1.23) | 118,564 | 121,585 | 97.5 | 2.01 (1.91–2.12) | 1.18 (1.11–1.26) | |
Apprenticeship | 2965 | 2999 | 98.9 | 1.19 (0.86–1.72) | 0.83 (0.59–1.20) | 2910 | 2999 | 97.0 | 1.68 (1.36–2.09) | 1.12 (0.91–1.40) | |
Other | 9405 | 9642 | 97.5 | 0.54 (0.47–0.63) | 0.97 (0.82–1.16) | 9060 | 9642 | 94.0 | 0.80 (0.73–0.88) | 1.06 (0.95–1.17) | |
Recorded religion | No religion | 187,177 | 188,816 | 99.1 | Baseline | Baseline | 18,2806 | 188,816 | 96.8 | Baseline | Baseline |
Christianity | 214,191 | 216,089 | 99.1 | 0.99 (0.92–1.06) | 1.11 (1.03–1.19) | 209,973 | 216,089 | 97.2 | 1.13 (1.09–1.17) | 1.09 (1.05–1.13) | |
Buddhism | 1093 | 1146 | 95.4 | 0.18 (0.14–0.24) | 0.40 (0.29–0.56) | 1044 | 1146 | 91.1 | 0.34 (0.28–0.42) | 0.56 (0.45–0.71) | |
Islam | 9219 | 9342 | 98.7 | 0.66 (0.55–0.79) | 1.45 (1.13–1.87) | 8961 | 9342 | 95.9 | 0.77 (0.70–0.86) | 1.42 (1.23–1.66) | |
Other religions | 2344 | 2412 | 97.2 | 0.30 (0.24–0.39) | 0.38 (0.30–0.50) | 2251 | 2412 | 93.3 | 0.46 (0.39–0.54) | 0.51 (0.43–0.60) | |
Paganism | * | * | * | 0.22 (0.15–0.32) | 0.32 (0.22–0.48) | 729 | 797 | 91.5 | 0.35 (0.28–0.46) | 0.43 (0.33–0.56) | |
Hinduism | * | * | * | 1.00 (0.51–2.33) | 1.70 (0.83–4.08) | 776 | 803 | 96.6 | 0.94 (0.66–1.42) | 1.34 (0.90–2.07) | |
UK Born | Yes | 410,890 | 414,182 | 99.2 | Baseline | Baseline | 40,2474 | 414,182 | 97.2 | Baseline | Baseline |
No | 4696 | 5223 | 89.9 | 0.07 (0.06–0.08) | 0.21 (0.18–0.25) | 4066 | 5223 | 77.8 | 0.10 (0.10–0.11) | 0.23 (0.21–0.26) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Perry, M.; Cottrell, S.; Gravenor, M.B.; Griffiths, L. Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era. Vaccines 2023, 11, 680. https://doi.org/10.3390/vaccines11030680
Perry M, Cottrell S, Gravenor MB, Griffiths L. Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era. Vaccines. 2023; 11(3):680. https://doi.org/10.3390/vaccines11030680
Chicago/Turabian StylePerry, Malorie, Simon Cottrell, Michael B. Gravenor, and Lucy Griffiths. 2023. "Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era" Vaccines 11, no. 3: 680. https://doi.org/10.3390/vaccines11030680
APA StylePerry, M., Cottrell, S., Gravenor, M. B., & Griffiths, L. (2023). Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era. Vaccines, 11(3), 680. https://doi.org/10.3390/vaccines11030680